Valence8 Us LP Novo Nordisk A S Transaction History
Valence8 Us LP
- $213 Billion
- Q1 2025
A detailed history of Valence8 Us LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Valence8 Us LP holds 3,900 shares of NVO stock, worth $269,763. This represents 0.19% of its overall portfolio holdings.
Number of Shares
3,900Holding current value
$269,763% of portfolio
0.19%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NVO
# of Institutions
1,768Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.3 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.02 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$857 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$852 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$821 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $156B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...